Articles

AstraZeneca

AstraZeneca’s IMFINZI® Demonstrates Promising Results in POTOMAC Phase III Trial for High-Risk NMIBC

WILMINGTON, DE — AstraZeneca has announced positive high-level results from its Phase III POTOMAC trial assessing the efficacy of IMFINZI® (durvalumab) combined with standard-of-care Bacillus Calmette-Guérin (BCG) induction and maintenance …

AstraZeneca’s IMFINZI® Demonstrates Promising Results in POTOMAC Phase III Trial for High-Risk NMIBC Read More


Celebration Key

ICYMI: Carnival Cruise Line Partners with Cantaloupe, Inc. to Introduce Advanced POS Technology at Celebration Key

MALVERN, PA — Cantaloupe, Inc. (Nasdaq: CTLP) has announced a strategic collaboration with Carnival Cruise Line to implement cutting-edge point-of-sale (POS) technology at Celebration Key, Carnival’s highly anticipated cruise destination …

ICYMI: Carnival Cruise Line Partners with Cantaloupe, Inc. to Introduce Advanced POS Technology at Celebration Key Read More